Trifecta Capital

Trifecta Capital is a Gurugram-based premier Indian venture debt and equity fund backing high-growth digital health and consumer brands, with Series B, Series C, and growth-stage checks in the $5M to $25M range. The firm’s distinctive positioning is venture debt expertise alongside equity, which means founders can access non-dilutive growth capital structured to extend runway, fund inventory or working capital, or bridge to specific milestones. Healthcare relevance is digital health and care delivery tech-enabled services, with the fund’s appetite skewing toward category leaders at meaningful revenue scale. Founders pursuing early-stage AI experiments, biotech, or sub-scale niches should look elsewhere. The right counterparty is a CEO of a growth-stage Indian digital health or consumer healthcare brand with strong unit economics, established cohort retention, and a clear use case for growth capital, whether equity, debt, or a hybrid structure. Trifecta is most useful when the founder understands venture debt’s discipline and the structural difference from pure equity, including covenants, repayment schedules, and the implications for next-round structuring. Geographic and structural advantage is the Indian growth-stage network, debt-and-equity flexibility that few Indian firms offer at this scale, and connectivity into Indian Tier-1 PE and global growth investors at Series C and beyond. Best entry is via Indian Tier-1 venture syndicates that have co-invested with Trifecta, banker-introduced processes for venture debt, or direct outreach when revenue and capital strategy fit. The team is small and selective, and venture debt diligence is rigorous, including covenant negotiation, security structuring, and downside-case modeling. Lead the pitch with audited financials, cohort and operational metrics, capital-strategy clarity on equity-versus-debt, and a credible exit pathway. Be explicit about regulator and clinical quality posture, DPDP compliance, and any related-party transactions that surface during diligence. Caveats: venture debt is structurally different from equity, including the covenants, board observer rights, and repayment obligations that affect the cap table and operational flexibility. Founders unfamiliar with venture debt should engage experienced counsel before signing terms. Ask Trifecta directly about debt-to-equity ratio, covenants, prepayment terms, and how the fund handles distressed scenarios. Confirm fund vintage and remaining deployment. Reference checks with current portfolio CEOs on debt structuring experience, operating support, and behavior through difficult quarters are particularly important. Used appropriately, Trifecta is one of the more credible Indian venture-debt-and-equity partners for digital health and consumer healthcare CEOs at scale; for early-stage founders, it is structurally premature.